{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:17:00Z","timestamp":1790788620281,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11605-018-3966-8","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T18:34:38Z","timestamp":1537554878000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Ammar A.","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex B.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Makary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Laheru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0010","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA: a Cancer Journal for Clinicians."},{"issue":"5","key":"10.1007\/s11605-018-3966-8_bb0015","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA: a Cancer Journal for Clinicians."},{"key":"10.1007\/s11605-018-3966-8_bb0020","doi-asserted-by":"crossref","unstructured":"Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA et al. Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. Annals of Surgery. 2018. https:\/\/doi.org\/10.1097\/SLA.0000000000002734.","DOI":"10.1097\/SLA.0000000000002734"},{"issue":"8","key":"10.1007\/s11605-018-3966-8_bb0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","article-title":"Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Tempero","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN."},{"key":"10.1007\/s11605-018-3966-8_bb0030","doi-asserted-by":"crossref","unstructured":"Javed AA, Bleich K, Bagante F, He J, Weiss MJ, Wolfgang CL et al. Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings. Abdominal Radiology (New York). 2017. https:\/\/doi.org\/10.1007\/s00261-017-1290-5.","DOI":"10.1007\/s00261-017-1290-5"},{"issue":"31","key":"10.1007\/s11605-018-3966-8_bb0035","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.3748\/wjg.v20.i31.10740","article-title":"Borderline resectable pancreatic cancer: definitions and management","volume":"20","author":"Lopez","year":"2014","journal-title":"World Journal of Gastroenterology."},{"issue":"3","key":"10.1007\/s11605-018-3966-8_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11864-013-0244-6","article-title":"Treatment of borderline resectable pancreatic cancer","volume":"14","author":"Cooper","year":"2013","journal-title":"Current Treatment Options in Oncology."},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1477-2574.2009.00136.x","article-title":"Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer","volume":"12","author":"McClaine","year":"2010","journal-title":"HPB: the Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"4","key":"10.1007\/s11605-018-3966-8_bb0050","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1245\/s10434-014-4225-1","article-title":"Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas","volume":"22","author":"Blazer","year":"2015","journal-title":"Annals of Surgical Oncology."},{"issue":"7","key":"10.1007\/s11605-018-3966-8_bb0055","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1245\/s10434-009-0413-9","article-title":"Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement","volume":"16","author":"Abrams","year":"2009","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000658-199501000-00007","article-title":"Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?","volume":"221","author":"Nitecki","year":"1995","journal-title":"Annals of Surgery."},{"issue":"5","key":"10.1007\/s11605-018-3966-8_bb0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/fon.15.335","article-title":"The role of neoadjuvant therapy in pancreatic cancer: a review","volume":"12","author":"Russo","year":"2016","journal-title":"Future Oncology."},{"issue":"5","key":"10.1007\/s11605-018-3966-8_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2007.12.020","article-title":"Borderline resectable pancreatic cancer: the importance of this emerging stage of disease","volume":"206","author":"Katz","year":"2008","journal-title":"Journal of the American College of Surgeons."},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology: official journal of the International Association of Pancreatology."},{"key":"10.1007\/s11605-018-3966-8_bb0080","doi-asserted-by":"crossref","unstructured":"Jang JY, Han Y, Lee H, Kim SW, Kwon W, Lee KH et al. Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2\/3 Trial. Annals of Surgery. 2018. https:\/\/doi.org\/10.1097\/SLA.0000000000002705.","DOI":"10.1097\/SLA.0000000000002705"},{"issue":"6","key":"10.1007\/s11605-018-3966-8_bb0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jso.24723","article-title":"Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma","volume":"116","author":"Epstein","year":"2017","journal-title":"Journal of Surgical Oncology."},{"issue":"21","key":"10.1007\/s11605-018-3966-8_bb0090","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.2007.15.8634","article-title":"Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head","volume":"26","author":"Evans","year":"2008","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology."},{"issue":"4","key":"10.1007\/s11605-018-3966-8_bb0095","doi-asserted-by":"crossref","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Medicine."},{"issue":"5","key":"10.1007\/s11605-018-3966-8_bb0100","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.surg.2017.11.027","article-title":"Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy","volume":"163","author":"Blair","year":"2018","journal-title":"Surgery."},{"key":"10.1007\/s11605-018-3966-8_bb0105","doi-asserted-by":"crossref","unstructured":"Kommalapati A, Tella SH, Goyal G, Ma WW, Mahipal A. Contemporary Management of Localized Resectable Pancreatic Cancer. Cancers. 2018;10(1). https:\/\/doi.org\/10.3390\/cancers10010024.","DOI":"10.3390\/cancers10010024"},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12957-017-1240-2","article-title":"Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients","volume":"15","author":"Dhir","year":"2017","journal-title":"World Journal of Surgical Oncology."},{"issue":"8","key":"10.1007\/s11605-018-3966-8_bb0115","doi-asserted-by":"crossref","first-page":"e161137","DOI":"10.1001\/jamasurg.2016.1137","article-title":"Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101","volume":"151","author":"Katz","year":"2016","journal-title":"JAMA Surgery."},{"issue":"2","key":"10.1007\/s11605-018-3966-8_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.prro.2017.10.001","article-title":"Results of a prospective phase 2 clinical trial of induction gemcitabine\/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma","volume":"8","author":"Quan","year":"2018","journal-title":"Practical Radiation Oncology."},{"issue":"4","key":"10.1007\/s11605-018-3966-8_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4174\/astr.2017.93.4.186","article-title":"Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer","volume":"93","author":"Kim","year":"2017","journal-title":"Annals of Surgical Treatment and Research."},{"key":"10.1007\/s11605-018-3966-8_bb0130","doi-asserted-by":"crossref","unstructured":"Gemenetzis G, Groot VP, Blair AB, Laheru DA, Zheng L, Narang AK et al. Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. Annals of Surgery. 2018. https:\/\/doi.org\/10.1097\/SLA.0000000000002753.","DOI":"10.1097\/SLA.0000000000002753"},{"key":"10.1007\/s11605-018-3966-8_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-199","article-title":"A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma","volume":"12","author":"Hosein","year":"2012","journal-title":"BMC Cancer."},{"issue":"5","key":"10.1007\/s11605-018-3966-8_bb0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2214\/AJR.17.18310","article-title":"Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy","volume":"210","author":"Joo","year":"2018","journal-title":"AJR: American Journal of Roentgenology."},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Annals of Surgery."},{"issue":"7","key":"10.1007\/s11605-018-3966-8_bb0150","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/cam4.1104","article-title":"Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer","volume":"6","author":"Shrestha","year":"2017","journal-title":"Cancer Medicine."},{"issue":"1","key":"10.1007\/s11605-018-3966-8_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/s12885-017-3441-z","article-title":"Alliance for Clinical Trials in Oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas","volume":"17","author":"MHG","year":"2017","journal-title":"BMC Cancer."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-018-3966-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-018-3966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23031414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23031414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-018-3966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:56:14Z","timestamp":1761076574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23031414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1091255X23031414"],"URL":"https:\/\/doi.org\/10.1007\/s11605-018-3966-8","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-018-3966-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}